Filter Results:
(5,861)
Show Results For
- All HBS Web
(5,861)
- People (21)
- News (2,292)
- Research (2,892)
- Events (4)
- Multimedia (222)
- Faculty Publications (2,100)
Show Results For
- All HBS Web
(5,861)
- People (21)
- News (2,292)
- Research (2,892)
- Events (4)
- Multimedia (222)
- Faculty Publications (2,100)
- January 2, 2020
- Article
Changes in Quality of Care After Hospital Mergers and Acquisitions
By: Nancy Dean Beaulieu, Leemore S. Dafny, B. E. Landon, Jesse Dalton, Ifedayo Kuye and J. Michael McWilliams
Background: The hospital industry has consolidated substantially during the past two decades and at an accelerated pace since 2010. Multiple studies have shown that hospital mergers have led to higher prices for commercially insured patients, but research about effects... View Details
Beaulieu, Nancy Dean, Leemore S. Dafny, B. E. Landon, Jesse Dalton, Ifedayo Kuye, and J. Michael McWilliams. "Changes in Quality of Care After Hospital Mergers and Acquisitions." New England Journal of Medicine 382, no. 1 (January 2, 2020): 51–59.
- 01 Feb 1997
- News
Herzlinger on Health Care: Revolution in Evolution
use expensive technology, which many people cite as the reason for high U.S. health-care costs? Actually,the opposite is true: advances in medical technology have made health care cheaper and better - and... View Details
- February 1999 (Revised March 2000)
- Case
Beth Israel Deaconess Medical Center: Coordinating Patient Care
External cost pressures are motivating the adoption of case management (CM) at Beth Israel Deaconess Medical Center (BIDMC), but several of the organization's key professional groups are working against it. President and CEO David Dolins must decide whether CM is... View Details
Keywords: Organizational Change and Adaptation; Service Operations; Organizational Culture; Health Care and Treatment; Health Industry; Boston
Gittell, Jody H., Kristin Shu, and Julian Wimbush. "Beth Israel Deaconess Medical Center: Coordinating Patient Care." Harvard Business School Case 899-213, February 1999. (Revised March 2000.)
- 02 Mar 2007
- What Do You Think?
What Is the Government’s Role in US Health Care?
government's role in U.S. healthcare? What do you think? To Read More: Robert H. Frank, "A Health Care Plan So Simple, Even Stephen Colbert Couldn't Simplify It," The New York Times, February 18, 2007, p.... View Details
- June 2013
- Supplement
Boston Children's Hospital Assignment Worksheet
By: Robert S. Kaplan
- 14 Dec 2013
- News
IT Start-Up Eases Health Plan Hiccups
- 01 Sep 2011
- News
Student Trio Advance Health Payment Reform
Related Links Read about other efforts in healthcare delivery Three HBS students spent much of the last academic year helping a leading Boston hospital answer one of the most important questions in health-care management: how to create a new payment system that saves... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
help achieve better access to care and a lower cost of care. And employers are embracing telemedicine as a way to provide employees convenient health care at a lower cost for... View Details
- May 2016
- Case
AbbVie
By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details
- February 1996 (Revised April 2004)
- Case
Eli Lilly and Company: Innovation in Diabetes Care
By: Clayton M. Christensen
Summarizes Eli Lilly's history of innovation in its business, describing how the dimensions along which innovations have been made in the industry have changed. Lilly's innovation strategy has been to pursue ever higher performance products, while others in the... View Details
Keywords: Change; Product; Service Delivery; Product Development; Innovation and Management; Innovation Strategy; Health Care and Treatment; Pharmaceutical Industry
Christensen, Clayton M. "Eli Lilly and Company: Innovation in Diabetes Care." Harvard Business School Case 696-077, February 1996. (Revised April 2004.)
- September–October 2023
- Article
Prospective Evaluation of the Cost of Performing Breast Imaging Examinations Using Time-Driven Activity-Based Costing Method: A Single Center Study
By: Aamir Ali, Jordana Phillips, Damir Ljuboja, Syed S. Shehab, Etta D. Pisano, Robert S. Kaplan and Ammar Sarwar
We use time-driven activity-based costing (TDABC) to measure the cost of performing breast imaging using different modalities: full-field digital mammography (FFDM), digital breast tomosynthesis (DBT), contrast-enhanced mammography (CEM), US and MRI exams, and... View Details
Keywords: Time-Driven Activity-Based Costing; Health Care; Breast Cancer; Health Care and Treatment; Cost; Cost Accounting; Health Industry
Ali, Aamir, Jordana Phillips, Damir Ljuboja, Syed S. Shehab, Etta D. Pisano, Robert S. Kaplan, and Ammar Sarwar. "Prospective Evaluation of the Cost of Performing Breast Imaging Examinations Using Time-Driven Activity-Based Costing Method: A Single Center Study." Journal of Breast Imaging 5, no. 5 (September–October 2023): 546–554.
- October–December 2005
- Article
Medicine's Service Challenge: Blending Custom and Standard Care
By: Richard Bohmer
Bohmer, Richard. "Medicine's Service Challenge: Blending Custom and Standard Care." Health Care Management Review 30, no. 4 (October–December 2005): 322–330.
- July 2021 (Revised July 2022)
- Case
Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care
By: Robert S. Kaplan, Navraj S. Nagra and Syed S. Shehab
Dr. Andrea Pusic, breast cancer reconstruction surgeon, wants to extend outcomes measurement beyond traditional surgical metrics of infections, complications, and survival rates. The case describes her development of a new mobile phone app, which collects patients’... View Details
Keywords: Health Care and Treatment; Outcome or Result; Cost Management; Activity Based Costing and Management; Mobile and Wireless Technology; Health Testing and Trials; Surveys; Health Industry; Boston
Kaplan, Robert S., Navraj S. Nagra, and Syed S. Shehab. "Brigham & Women's Hospital: Using Patient Reported Outcomes to Improve Breast Cancer Care." Harvard Business School Case 122-010, July 2021. (Revised July 2022.)
- 28 Nov 2016
- News
What’s good for employee health is good for the company
- March 2018
- Case
Sandra Brown Goes Digital (A): The Promise and Perils of Social Movements in a Healthcare Company
By: Rosabeth Moss Kanter and Jonathan Cohen
As a middle manager at a biotechnology company, Sandra Brown harnessed digital tools and social media to engage others and build campaigns for change in the company. This case follows her career at the company and describes the challenges she faced as a change agent,... View Details
Keywords: Digital; Engagement; Stakeholder Engagement; Grassroots Movement; Organization Change And Adaptation; Quality; Health Care; Health Care Industry; Career Path; Leading Change; Management; Innovation and Management; Personal Development and Career; Organizational Change and Adaptation; Health Industry; Health Industry
Kanter, Rosabeth Moss, and Jonathan Cohen. "Sandra Brown Goes Digital (A): The Promise and Perils of Social Movements in a Healthcare Company." Harvard Business School Case 318-082, March 2018.
- 01 Dec 2007
- News
Where Are the Innovators in Health Care?
billion of the excessive costs of U.S. health care while all too many quality measures have worsened. Patients learn — sometimes the hard way — to bring along an assertive, intelligent loved one to protect... View Details
- Article
The Aravind Eye Care System: Making Sight Affordable
By: V. Kasturi Rangan and R. D. Thulasiraj
Keywords: Health Care and Treatment
Rangan, V. Kasturi, and R. D. Thulasiraj. "The Aravind Eye Care System: Making Sight Affordable." Innovations: Technology, Governance, Globalization 2, no. 4 (Fall 2007): 35–52.
- March 2014
- Editorial
Limits on Use of Health Economic Assessments for Rare Diseases
By: Hanna I. Hyry, Ariel Dora Stern, Jonathan CP Roos and Timothy M. Cox
Funding of expensive treatments for rare ('orphan') diseases is contentious. These agents fare poorly on 'efficiency' or health economic measures, such as the QALY, because of high cost and frequently poor gains in quality of life and survival. We show that... View Details
Hyry, Hanna I., Ariel Dora Stern, Jonathan CP Roos, and Timothy M. Cox. "Limits on Use of Health Economic Assessments for Rare Diseases." hcu016. QJM: An International Journal of Medicine 107, no. 3 (March 2014): 241–245.
- Article
Consumer-Driven Health Care: Freeing Providers to Innovate
Herzlinger, Regina E. "Consumer-Driven Health Care: Freeing Providers to Innovate." hfm (Healthcare Financial Management) 58, no. 3 (March 2004): 66–68.